Contact this trialFirst, we need to learn more about you.
mTOR Inhibitor
Radioactive Drug vs Everolimus for Neuroendocrine Cancer
Recruiting1 awardPhase 2
DeKalb, Illinois
This trial compares a radioactive drug linked to a peptide receptor with a drug that stops cancer cells from reproducing to treat neuroendocrine tumors.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service